MHRA Dianette Update
May 16, 2006 on 1:16 pm | In Prescribing Extra - Drugs |
Print
|
The Medicines and Healthcare products Regulatory Agency has issued an update on the use of Dianette®. The MHRA are currently reviewing the description of psychiatric reactions in the product information.
Dianette is a hormonal medication that is licensed for the treatment of severe acne that fails to respond to antibiotics and moderately severe hirsutism. Dianette also acts as a contraceptive but should not be used for this purpose alone or as a contraceptive in patients with mild acne.
Venous thromboembolism occurs more often in patients treated with dianette than those treated with low-dose combined oral contraceptives. Depression is also a known side effect of dianette.
Action: Clinicians should only prescribe dianette within the product license, review regularly and withdraw treatment upon resolution of symptoms. Repeat courses can be given if symptoms return.
Bookmark in del.icio.us
16 year old daughter prescribed Dianette for acne 5 months ago. Increased risk of thrombosis compared to other hormone treatments for acne not mentioned at GP consultation. Daughter has had an acute DVT.
Suspected cause of the DVT is dianette
Comment by LA MacKinnon — March 6, 2008 #
I do hope that your daughter is recovering well.
Comment by Matthew Robinson — March 10, 2008 #